Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection

Journal of Gastroenterology

Volumn 41, Issue 5, 2006, Pages 470-475

  Uka, Kiminori ^a   Suzuki, Fumitaka ^a   Akuta, Norio ^a   Sezaki, Hitomi ^a   Suzuki, Yoshiyuki ^a   Hosaka, Tetsuya ^a   Someya, Takashi ^a   Kobayashi, Masahiro ^a   Saitoh, Satoshi ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

HCV; Interferon therapy; Young patients

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; DRUG EFFICACY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTIVARIATE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; BIOPSY; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; KOREA; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD;

EID: 33745400075     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1793-2     Document Type: Article

References (34)

1. C Niederau S Lange T Heintges A Erhardt M Buschkamp D Hurter 1998 Prognosis of chronic hepatitis C: Results of a large, prospective cohort study Hepatology 28 1687-95 9828236 1:STN:280:DyaK1M%2FkslGitQ%3D%3D 10.1002/hep.510280632
2. GM Dusheiko 1998 The natural course of chronic hepatitis C: Implications for clinical practice J Viral Hepat 5 9-12 9795923 10.1046/ j.1365-2893.1998.0050s1009.x
3. K Ikeda S Saitoh Y Suzuki M Kobayashi A Tsubota I Koida 1998 Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients J Hepatol 28 930-8 9672166 1:CAS:528:DyaK1cXmvVSltL0%3D 10.1016/S0168-8278(98)80339-5
4. E Kenny-Walsh 1999 Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group N Engl J Med 22 1228-33 10.1056/NEJM199904223401602
5. K Chayama S Saitoh Y Arase K Ikeda T Matsumoto Y Sakai 1991 Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C Hepatology 13 1040-3 1711001 1:STN:280:By6B28jksFM%3D 10.1016/0270-9139(91)92469-O
6. O Reichard H Glaumann A Fryden G Norkrans R Schvarcz A Sonnerborg 1995 Two-year biochemical, virological and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alpha-2β treatment Hepatology 21 918-22 7705800 1:STN:280:ByqB38%2Foslc%3D 10.1016/0270-9139(95)90234-1
7. A Kasahara N Hayashi K Mochizuki M Takayanagi K Yoshioka S Kakumu 1998 Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1394-402 9581697 1:CAS:528:DyaK1cXjtVSjt7Y%3D 10.1002/hep.510270529
8. T Moriya T Koyama J Tanaka S Mishiro H Yoshizawa 1999 Epidemiology of hepatitis C virus in Japan Intervirology 42 153-8 10516469 1:STN:280:DyaK1MvkslOjtg%3D%3D 10.1159/000024974
9. HJ Alter D Kruszon-Moran OV Nainan 1998 The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556-62 10.1056/NEJM199908193410802
10. S Mauses F Berger J Goeiz B Jacob G Schmutz 2004 A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance Hepatology 40 120-4 10.1002/hep.20279
11. JG McHuchison SC Gordon ER Schiff ML Shiffmann WM Lee VK Rustgi 1998 Interferon alpha 2β alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 339 1485-92 10.1056/NEJM199811193392101
12. O Reichard G Norkrans A Fryden 1998 Randomised double-blind, placebo controlled trial of interferon alpha 2b with and without ribavirin for chronic hepatitis C Lancet 351 83-7 9439491 1:CAS:528:DyaK1cXmsFSqtw%3D%3D 10.1016/S0140-6736(97)06088-1
13. L Kilham VH Ferm 1977 Congenital anomalies induced in hamster embryos with ribavirin Science 195 413-4 401547 1:CAS:528:DyaE2sXhtVWjsLw%3D
14. EM Johnson 1990 The effects of ribavirin on development and reproduction: A critical review of published and unpublished studies in experimental animals J Am Coll Toxicol 9 551-61 1:CAS:528:DyaK3MXitl2lurs%3D
15. D Prati A Zanella F Zanuso L Vianello E Della Torre F Mozzi 2000 Sustained response to interferon-α2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C J Viral Hepat 7 352-60 10971823 1:STN:280:DC%2BD3M%2Fjs12ksQ%3D%3D 10.1046/ j.1365-2893.2000.00240.x
16. MA Casiraghi M De Paschale L Romano R Biffi A Assi G Binelli 2004 Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth Hepatology 39 90-6 14752827 10.1002/hep.20030
17. VJ Desmet M Gerber JH Hoofnagale M Manns PJ Sheuer 1994 Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1513-20 8188183 1:STN:280:ByuB2crhtFU%3D 10.1016/0270-9139(94)90250-X
18. M Hashimoto K Chayama A Tsubota M Kobayashi A Nakano K Takagi 1996 Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region Int Hepatol Commun 4 263-7 10.1016/0928-4346(96)00257-5
19. JH Hoofnagle AM Di Bisceglie 1997 The treatment of chronic viral hepatitis N Engl J Med 336 347-56 9011789 1:STN:280:ByiC2Mnit10%3D 10.1056/NEJM199701303360507
20. JY Lau GL Davis J Kniffen KP Qian MS Urdea CS Chan 1993 Significance of serum hepatitis C virus RNA levels in chronic hepatitis C Lancet 341 1501-4 8099380 1:STN:280:ByyB1c%2FovFY%3D 10.1016/0140-6736(93)90635-T
21. A Tsubota K Chayama K Ikeda A Yasuji I Koida S Saitoh 1994 Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection Hepatology 19 1088-94 8175130 1:STN:280:ByuB38bnsVQ%3D 10.1016/ 0270-9139(94)90854-0
22. S Mamori F Suzuki T Hosaka N Akuta T Someya M Kobayashi 2004 Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment J Gastroenterol 39 776-82 15338372 1:CAS:528:DC%2BD2cXntVaqur8%3D 10.1007/s00535-003-1388-0
23. F Tine S Magrin A Craxi L Pagliaro 1991 Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomized clinical trials J Hepatol 13 192-9 1835989 1:STN:280:By2D2sfmt10%3D 10.1016/ 0168-8278(91)90814-R
24. E Jaeckel M Cornberg H Wedemeyer T Santantonio J Mayer D Zankel 2001 Treatment of acute hepatitis C with interferon alpha-2b N Engl J Med 345 1452-7 11794193 1:CAS:528:DC%2BD3MXovVaqs70%3D 10.1056/NEJMoa011232
25. T Gerlach R Zachoval N Gruener MC Jung A Ulsenheimer W Schraut 2001 Acute hepatitis C: Natural course and response to antiviral treatment (abstract) Hepatology 34 341A.
26. SM Kamal A Ismail CS Graham Q He JW Rasenack T Peters 2004 Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus-specific T cell response kinetics Hepatology 39 1721-31 15185314 1:CAS:528:DC%2BD2cXlsVWrt74%3D 10.1002/hep.20266
27. H Nomura S Sou H Tanimoto T Nagahama Y Kimura J Hayashi 2004 Short-term interferon-alpha therapy for acute hepatitis C: A randomized controlled trial Hepatology 39 1213-9 15122749 1:CAS:528:DC%2BD2cXks1Sjtrs%3D 10.1002/hep.20196
28. M Fernandez JA Quiroga J Martin M Herrero M Pardo MA Horisberger 1999 In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus J Infect Dis 180 262-7 10395838 1:CAS:528:DyaK1MXlt1ygsLs%3D 10.1086/314859
29. G Antonelli E Simeoni O Turriziani R Tesoro A Redaelli L Roffi 1999 Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-α therapy J Interferon Cytokine Res 19 243-51 10213463 1:CAS:528:DyaK1MXitlOlsLk%3D 10.1089/107999099314171
30. S Takaki A Tsubota T Hosaka N Akuta T Someya M Kobayashi 2004 Factors contributing to ribavirin dose reduction due to anemia during interferon alpha2b and ribavirin combination therapy for chronic hepatitis C J Gastroenterol 39 668-73 15293138 1:CAS:528:DC%2BD2cXmt1Kktb4%3D 10.1007/ s00535-003-1363-9
31. H Nomura H Tanimoto E Kajiwara J Shimono T Maruyama N Yamashita 2004 Factors contributing to ribavirin-induced anemia Gastroenterol Hepatol 19 1312-7 1:CAS:528:DC%2BD2cXhtVKnt7vF 10.1111/j.1440-1746.2004.03459.x
32. Y Arase F Suzuki A Tsubota Y Suzuki S Saitoh M Kobayashi 2004 Sustained negativity for HCV-RNA over 24 or more months by long-term interferon therapy correlates with eradication of HCV in patients with hepatitis C virus genotype 1b and high viral load Intervirology 47 19-25 15044832 1:CAS:528:DC%2BD2cXisFOqsrk%3D 10.1159/000076638
33. G Saracco E Borghesio P Mesina A Solinas C Spezia F Macor 1997 Prolonged treatment (2 years) with different doses (3 versus 6MU) of interferon 2b for chronic hepatitis type C J Hepatol 27 56-62 9252074 1:CAS:528:DyaK2sXltVOrs7o%3D 10.1016/S0168-8278(97)80280-2
34. H Nomura H Tanimoto S Sou T Nagahama J Hayashi S Kashiwagi 2003 Pilot study of prolonged interferon-α retreatment in chronic hepatitis C patients with genotype 1b Hepatol Res 27 266-71 14662114 1:CAS:528:DC%2BD3sXps1Ors7c%3D 10.1016/S1386-6346(03)00271-7